Mechanism of Action of Adalimumab (Humira)
Introduction Adalimumab is a fully human monoclonal IgG1 antibody that specifically targets tumor necrosis factor‑α (TNF‑α). By neutralizing … Read more
Introduction Adalimumab is a fully human monoclonal IgG1 antibody that specifically targets tumor necrosis factor‑α (TNF‑α). By neutralizing … Read more
Introduction Entyvio (vedolizumab) is a recombinant humanized IgG1 monoclonal antibody that targets the α4β7 integrin on gut-homing T-lymphocytes. … Read more
Introduction Etanercept is a biologic fusion protein that functions as a soluble tumor necrosis factor (TNF) receptor. By … Read more
Introduction Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used medications globally. They are primarily prescribed for … Read more
Introduction Tofacitinib is an oral Janus kinase (JAK) inhibitor, primarily targeting JAK1 and JAK3. It blocks intracellular signaling … Read more
Introduction Liraglutide is a long-acting GLP‑1 receptor agonist, injected once daily. It’s used for type 2 diabetes mellitus … Read more
Introduction SGLT2 inhibitors, also known as “gliflozins,” are a class of oral antidiabetic agents primarily used to manage … Read more
Introduction Semaglutide is a long-acting glucagon-like peptide-1 receptor agonist (GLP-1 RA) used for type 2 diabetes mellitus (T2DM) management … Read more
Introduction Tolvaptan is an oral vasopressin V₂ receptor antagonist, approved for treating hyponatremia due to SIADH, heart failure, … Read more
Introduction Tocilizumab is a humanized monoclonal antibody targeting the interleukin-6 receptor (IL-6R). It is approved for rheumatoid arthritis … Read more